KBC Group NV Purchases 253 Shares of Triumph Financial, Inc. (NASDAQ:TFIN)
Patriots downgrade starting center Ben Brown to out on eve of Chargers matchup
Pathstone Holdings LLC cut its position in shares of Baker Hughes ( NASDAQ:BKR – Free Report ) by 15.6% during the 3rd quarter, HoldingsChannel reports. The firm owned 131,883 shares of the company’s stock after selling 24,365 shares during the period. Pathstone Holdings LLC’s holdings in Baker Hughes were worth $4,768,000 as of its most recent SEC filing. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in BKR. National Pension Service boosted its holdings in shares of Baker Hughes by 6.4% during the 3rd quarter. National Pension Service now owns 1,362,973 shares of the company’s stock valued at $49,271,000 after buying an additional 81,625 shares in the last quarter. Hixon Zuercher LLC purchased a new position in Baker Hughes during the 3rd quarter valued at about $1,980,000. Wedge Capital Management L L P NC boosted its stake in Baker Hughes by 20.5% during the second quarter. Wedge Capital Management L L P NC now owns 726,291 shares of the company’s stock worth $25,544,000 after acquiring an additional 123,689 shares in the last quarter. AQR Capital Management LLC grew its holdings in Baker Hughes by 7.6% in the second quarter. AQR Capital Management LLC now owns 6,424,915 shares of the company’s stock worth $223,523,000 after purchasing an additional 455,307 shares during the period. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Baker Hughes by 32.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 17,364,995 shares of the company’s stock valued at $581,729,000 after purchasing an additional 4,207,973 shares in the last quarter. 92.06% of the stock is owned by hedge funds and other institutional investors. Analyst Ratings Changes A number of analysts have recently commented on BKR shares. Morgan Stanley boosted their price target on Baker Hughes from $42.00 to $45.00 and gave the stock an “overweight” rating in a research report on Thursday, October 3rd. Argus raised Baker Hughes from a “hold” rating to a “buy” rating in a research note on Friday, October 25th. Benchmark reaffirmed a “buy” rating and issued a $42.00 price target on shares of Baker Hughes in a research report on Thursday, October 24th. The Goldman Sachs Group increased their price objective on shares of Baker Hughes from $39.00 to $43.00 and gave the company a “buy” rating in a research report on Monday, July 29th. Finally, JPMorgan Chase & Co. lifted their target price on shares of Baker Hughes from $42.00 to $43.00 and gave the stock an “overweight” rating in a report on Monday, July 29th. Two equities research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the stock. According to MarketBeat.com, Baker Hughes has a consensus rating of “Moderate Buy” and a consensus target price of $44.59. Baker Hughes Stock Down 1.4 % Baker Hughes stock opened at $44.25 on Friday. Baker Hughes has a one year low of $28.32 and a one year high of $45.17. The stock has a fifty day moving average of $38.54 and a 200 day moving average of $35.63. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.88 and a current ratio of 1.30. The stock has a market cap of $43.79 billion, a PE ratio of 19.84, a price-to-earnings-growth ratio of 0.76 and a beta of 1.38. Baker Hughes ( NASDAQ:BKR – Get Free Report ) last released its quarterly earnings results on Tuesday, October 22nd. The company reported $0.67 EPS for the quarter, beating the consensus estimate of $0.61 by $0.06. The firm had revenue of $6.91 billion during the quarter, compared to analyst estimates of $7.21 billion. Baker Hughes had a net margin of 8.20% and a return on equity of 13.77%. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.42 EPS. As a group, sell-side analysts predict that Baker Hughes will post 2.29 EPS for the current year. Baker Hughes Announces Dividend The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 14th. Stockholders of record on Monday, November 4th were given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 1.90%. The ex-dividend date of this dividend was Monday, November 4th. Baker Hughes’s payout ratio is 37.67%. Baker Hughes Profile ( Free Report ) Baker Hughes Company provides a portfolio of technologies and services to energy and industrial value chain worldwide. The company operates through Oilfield Services & Equipment (OFSE) and Industrial & Energy Technology (IET) segments. The OFSE segment designs and manufactures products and provides related services, including exploration, appraisal, development, production, rejuvenation, and decommissioning for onshore and offshore oilfield operations. See Also Want to see what other hedge funds are holding BKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baker Hughes ( NASDAQ:BKR – Free Report ). Receive News & Ratings for Baker Hughes Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baker Hughes and related companies with MarketBeat.com's FREE daily email newsletter .‘When Is It Time To Go?’ A Departing Senator’s Advice for DemocratsChandigarh Lit Fest kicks off with launch of book on Ratan Tata, talks on freedom struggle
49ers' Brock Purdy, Nick Bosa Ruled Out Against Packers
Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Stay in the know on jobs, retail and all things business across Long Island. By clicking Sign up, you agree to our privacy policy . Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.”
LOS ANGELES--(BUSINESS WIRE)--Dec 23, 2024-- Roland Corporation , a global leader in professional music products, has announced bold carbon reduction targets as part of its commitment to building a decarbonized society where artistic culture can flourish. In alignment with the Paris Agreement international treaty on climate change, Roland aims to reduce greenhouse gas emissions across its operations and value chain—paving the way for a sustainable future that supports creativity, music, and artistic expression. Reduction Targets Reduction targets are set in line with the concept of SBT*, with the goal of achieving carbon neutrality as declared in the Paris Agreement in mind. *SBT (Science Based Targets): Corporate greenhouse gas emission reduction targets consistent with the levels required by the Paris Agreement adopted in 2015. Current Progress and Results Total CO2 emissions in FY2023 were reduced by 12% from the previous year, and Roland will continue its efforts to reduce CO2 emissions further. Roland is dedicated to transparency in its ESG initiatives. Comprehensive ESG data is publicly available, showcasing Roland’s progress and commitment. Roland has also disclosed data on the content of its environmental (E), social (S), and governance (G) initiatives. For more information, see " ESG Data " in Roland's Sustainability section below. https://www.roland.com/global/sustainability/ Roland is committed to reducing its environmental footprint and leading by example in the music industry. Through these efforts, Roland aims to nurture a sustainable world where creativity, music, and artistic culture can continue to thrive. To learn more, visit Roland.com . About Roland Corporation For more than 50 years, Roland’s innovative electronic musical instruments and multimedia products have fueled inspiration in artists and creators around the world. Embraced by hobbyists and professionals alike, the company’s trendsetting gear spans multiple categories, from pianos, synthesizers, guitar products, drum and percussion products, DJ controllers, audio/video solutions, gaming mixers, livestreaming products, and more. As technology evolves, Roland and its expanding family of brands, including Roland Cloud, BOSS, V-MODA, Drum Workshop (DW), PDP, Latin Percussion (LP), and Slingerland, continue to lead the way for music makers and creators, providing modern solutions and seamless creative workflows between hardware products, computers, and mobile devices. For more information, visit Roland.com or see your local Roland dealer. Follow Roland on Facebook , Twitter ( @RolandGlobal ), and Instagram ( @RolandGlobal ). View source version on businesswire.com : https://www.businesswire.com/news/home/20241223420756/en/ CONTACT: Press: Farrah Monroe Max Borges Agency 240-483-6671 roland@maxborgesagency.com Company: Rebecca Genel Media Relations Manager Roland Corporation +1 (323) 890-3718 rebecca.genel@roland.com KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: PROFESSIONAL SERVICES ENTERTAINMENT ENVIRONMENTAL, SOCIAL AND GOVERNANCE (ESG) ENVIRONMENT SUSTAINABILITY MUSIC CLIMATE CHANGE SOURCE: Roland Copyright Business Wire 2024. PUB: 12/23/2024 01:00 PM/DISC: 12/23/2024 01:02 PM http://www.businesswire.com/news/home/20241223420756/enMumbai: Intra-country remittances through payment vehicles have dropped nearly 25-30% in November and December after the Reserve Bank of India (RBI) directed lenders to maintain detailed records of recipients, industry executives told ET. These new domestic money-transfer rules, which kicked in from November 1, are aimed at preventing the misuse of banking channels for online frauds. ET Year-end Special Reads Two sectors that rose on India's business horizon in 2024 2025 outlook: Is it time for cautious optimism or rekindling animal spirits? 2024: Govt moves ahead with simultaneous polls plan; India holds largest democratic exercise All leading players in the domestic money transfers (DMT) business, such as Fino Payments Bank , Airtel Payments Bank , NSDL Payments Bank , Spice Money, PayNearby, FIA Technology, and PayPoint, have seen a drop in business, said the executives cited above. "Implementing the new RBI guidelines is tough, and we had hoped the regulator would give us an extension," said an industry participant. "We have put in place APIs to conduct KYC of the remitter and store records of the recipient, but it's a cumbersome process. In the November and December period, business is down 30% month-on-month." Fino Payments Bank, one of the largest listed players in the domestic remittance business, has seen business drop more than 30% in November and December, industry sources revealed. Fino processes more than ₹3,500 crore in remittances every month. At the end of the September quarter, Fino had processed domestic transfers worth ₹10,453 crore. For the full fiscal year ending March 2024, total remittances stood at ₹52,695 crore. Artificial Intelligence(AI) Java Programming with ChatGPT: Learn using Generative AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Basics of Generative AI: Unveiling Tomorrows Innovations By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Generative AI for Dynamic Java Web Applications with ChatGPT By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Mastering C++ Fundamentals with Generative AI: A Hands-On By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) Master in Python Language Quickly Using the ChatGPT Open AI By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Performance Marketing for eCommerce Brands By - Zafer Mukeri, Founder- Inara Marketers View Program Office Productivity Zero to Hero in Microsoft Excel: Complete Excel guide 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance A2Z Of Money By - elearnmarkets, Financial Education by StockEdge View Program Marketing Modern Marketing Masterclass by Seth Godin By - Seth Godin, Former dot com Business Executive and Best Selling Author View Program Astrology Vastu Shastra Course By - Sachenkumar Rai, Vastu Shashtri View Program Strategy Succession Planning Masterclass By - Nigel Penny, Global Strategy Advisor: NSP Strategy Facilitation Ltd. View Program Data Science SQL for Data Science along with Data Analytics and Data Visualization By - Metla Sudha Sekhar, IT Specialist and Developer View Program Artificial Intelligence(AI) AI and Analytics based Business Strategy By - Tanusree De, Managing Director- Accenture Technology Lead, Trustworthy AI Center of Excellence: ATCI View Program Web Development A Comprehensive ASP.NET Core MVC 6 Project Guide for 2024 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital Marketing Masterclass by Pam Moore By - Pam Moore, Digital Transformation and Social Media Expert View Program Artificial Intelligence(AI) AI-Powered Python Mastery with Tabnine: Boost Your Coding Skills By - Metla Sudha Sekhar, IT Specialist and Developer View Program Office Productivity Mastering Microsoft Office: Word, Excel, PowerPoint, and 365 By - Metla Sudha Sekhar, IT Specialist and Developer View Program Marketing Digital marketing - Wordpress Website Development By - Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert View Program Office Productivity Mastering Google Sheets: Unleash the Power of Excel and Advance Analysis By - Metla Sudha Sekhar, IT Specialist and Developer View Program Web Development Mastering Full Stack Development: From Frontend to Backend Excellence By - Metla Sudha Sekhar, IT Specialist and Developer View Program Finance Financial Literacy i.e Lets Crack the Billionaire Code By - CA Rahul Gupta, CA with 10+ years of experience and Accounting Educator View Program Data Science SQL Server Bootcamp 2024: Transform from Beginner to Pro By - Metla Sudha Sekhar, IT Specialist and Developer View Program The impact on Airtel Payments Bank, another large domestic remitter, could not be immediately ascertained. Industry sources suggested the payments bank had seen a similar impact on its DMT business. NSDL Payments Bank, which processes nearly ₹2,000 crore of domestic remittances in a month, has seen business fall by more than 30%. It had processed Rs 24,000 crore in FY24. PayNearby, which processes close to ₹1,500 crore monthly transfers has seen a similar impact, sources said. Fino PB, NSDL PB, Airtel PB declined to comment. Spice Money & PayNearby did not respond to ETs query. DMT companies have suggested it would take another quarter for the industry to stabilise and achieve a "new normal". "The markets have dropped by 25-30%, but the sense is it will settle to a level lower than what it used to be," said an industry official, who did not wish to be named. "It will start stabilising in another quarter." As per RBI rules, there is a ₹25,000 monthly cap on DMT, with a daily limit capped at ₹5,000. These transactions also require second factor authentication as per the new rules that seek to curb money laundering. Industry sources suggest the domestic remittances industry has swelled to more than ₹2.5 lakh crore annually. Delhi, Mumbai, Indore, Rajasthan and Gujarat are among the major corridors from where a large chunk of the remittances originates. Bihar, Madhya Pradesh, Rajasthan and Uttar Pradesh are among the largest receivers of these inflows. Experts say that remittance flows are a good proxy of the state of the intra-country migrant economy. While conduits for such transfers vary, payment companies use NPCI's Aadhaar-enabled payment services and DMT channels such as bank-to- bank transfers through IMPS or NEFT. Nominations for ET MSME Awards are now open. The last day to apply is December 31, 2024. Click here to submit your entry for any one or more of the 22 categories and stand a chance to win a prestigious award. (You can now subscribe to our Economic Times WhatsApp channel )
Wedbush Brokers Reduce Earnings Estimates for TMC the metals
Admission fraud in Rajasthan: 9 MBBS grads lose case, face bar from practiceSouth Korea's president avoids an impeachment attempt over short-lived martial law